Outpatient Surgery Magazine - Subscribers

Throw Away The Script - Outpatient Surgery Magazine - February 2019

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/1080927

Contents of this Issue

Navigation

Page 123 of 150

cians continue to rec- ognize early stages of the disease. Patients are also becoming more aware of the following minimally invasive treatment options that can reduce the burden of a daily drop regimen. They might even show up at your facil- ity to have them done. • Sustained- release medications. IOP-lowering thera- pies can be delivered with injections, drug- eluting implants placed in the trabecu- lar meshwork, drug- impregnated punctal plugs and conjuncti- val polymer rings. Some say they could supplant topical drops as the pre- ferred non-surgical treatment method for Only the OMNI™ Surgical System allows you to target the three points of resistance in the conventional outflow pathway - trabecular meshwork, Schlemm's canal and distal collector channels - with one sophisticated, implant-free device. One MIGS device. Two implant-free procedures. Three points of resistance. For more patients. ©2019 Sight Sciences. All rights reserved. 06158.A Indications for use: The OMNI™ Surgical System is a manually operated device for delivery of small amounts of viscoelastic fluid, for example Healon® or HealonGV® from Abbott Medical Optics (AMO), Amvisc® from Bausch & Lomb, or PROVISC® from Alcon, during ophthalmic surgery. It is also indicated to cut trabecular meshwork tissue during trabeculotomy procedures. O M N I S U R G I C A L . C O M

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Subscribers - Throw Away The Script - Outpatient Surgery Magazine - February 2019